For example: Apple Inc, UTIL, Aluminum
Idera Pharmaceuticals Inc
NASDAQ:IDRA
Market Close 11/30
4.13 USD -0.16 (-3.73%)
OPEN:
4.29
DAY RANGE:
3.95 - 4.46
PE:
-1.61
PB:
1.18
PS:
44.91
WTD % -3.73
MTD % 50.18
QTD % 92.99
YTD % 126.92
* Updated at market close
Idera Pharmaceuticals Inc (NASDAQ:IDRA) opened on Nov 30, 2020 at 4.29 USD and slipped by -3.73%. The intraday price range was 3.95 - 4.46 USD and eventually ended the session at 4.13 USD. The stock trade volume was 274,600.00 shares. The company's 52-week range is 0.81 - 4.90 USD.
Trading Statistics (Market Close Nov 30, 2020)
Market Cap 145.37 M
Outstanding Stock 27.18 M
Dividend 0.00
Dividend Yield 0.00
EPS -1.66
YTD Change 126.92%
52 Week's Range 0.81 - 4.90
Key Ratio & Margins (Market Close Nov 30, 2020)
Price/Earning -1.61
Price/Book Value 1.18
Price/Sales 44.91
ROA -
ROE -
Debt/Equity 0.14
Company Self Description
Idera Pharmaceuticals, Inc. works in the field of design and develops drug candidates, including toll-like receptor-targeting technology and nucleic acid chemistry technology. The company uses two drug discovery technology platforms to researches on the discovery, development, and commercialization of oligonucleotide therapeutics for oncology and rare diseases in the United States. It was founded in 1989 and is based in Exton, Pennsylvania, United States.
Business Information
Idera Pharmaceuticals Inc
Sector Health Care
Industry Biotechnology
Exchange NASDAQ
Top Competitors (Market Close Nov 30, 2020)
  IDRA CKPT SESN SRRA
Daily Change (%) -3.73 1.27 2.48 -1.80
WTD (%) -3.73 1.27 2.48 -1.80
MTD (%) 50.18 9.59 21.57 1.68
QTD (%) 92.99 -10.45 -11.43 30.65
YTD (%) 126.92 39.53 19.23 1.90
52-Week Change (%) 136.00 81.82 5.08 0.43
Stock Performance (Market Close Nov 30, 2020)
  IDRA CKPT SESN SRRA
Daily Change (%) -3.73 1.27 2.48 -1.80
WTD (%) -3.73 1.27 2.48 -1.80
MTD (%) 50.18 9.59 21.57 1.68
QTD (%) 92.99 -10.45 -11.43 30.65
YTD (%) 126.92 39.53 19.23 1.90
52-Week Change (%) 136.00 81.82 5.08 0.43
Key Fundamentals (Market Close Nov 30, 2020)
  IDRA CKPT SESN SRRA
Market Cap 145.37 M 144.09 M 145.29 M 144.92 M
Revenue Growth - - - -
Net Income Growth - - - -
Profit Margin -2,713.10% -712.90% 0.00 0.00
P/E Ratio -1.61 -2.94 -1.50 -0.73
Price to Sales Ratio 44.91 22.32 0 0
Price to Book Ratio 1.18 5.25 2.49 1.04
Enterprise Value to EBITDA 0.12 -0.89 -1.56 0.25
ROA - -146.80% -70.30% -56.40%
ROE - -263.10% -220.50% -65.00%
Debt/Equity 0.14 1.11 1.52 0.16
Asset Turnover Ratio 0.03 0.21 0 0
Current Ratio 8.07 1.90 8.47 10.77
Dividend Yield 0.00 0 0 0
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Revenue 662,000.00 902,000.00 16.20 M 249,000.00
Cost Of Revenue 0.00 0.00 0.00 0.00
Gross Profit 662,000.00 902,000.00 16.20 M 249,000.00
Selling General & Administrative Expenses 15.42 M 15.59 M 15.13 M 15.40 M
Research & Development 41.84 M 50.65 M 39.82 M 33.70 M
Operating Income -60.96 M -66.47 M -38.76 M -48.85 M
Net Income -59.88 M -65.98 M -38.39 M -48.56 M
EPS -2.25 -3.35 -2.41 -3.36
Diluted EPS -2.25 -3.35 -2.41 -3.36
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Revenue 1.45 M 0.00 99,000.00 145,000.00
Cost Of Revenue 0.00 0.00 0.00 0.00
Gross Profit 1.45 M 0.00 99,000.00 145,000.00
Selling General & Administrative Expenses 2.90 M 3.14 M 3.57 M 3.98 M
Research & Development 10.02 M 8.10 M 8.93 M 8.86 M
Operating Income -11.52 M -11.38 M -12.50 M -11.88 M
Net Income -11.18 M -10.97 M -12.15 M -11.61 M
EPS -0.39 -0.40 -0.44 -0.43
Diluted EPS -0.39 -0.40 -0.44 -0.43
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Total Current Assets 72.81 M 116.62 M 111.04 M 63.24 M
Cash & Cash Equivalents 71.43 M 112.63 M 80.67 M 26.59 M
Total Assets 73.02 M 118.42 M 113.23 M 92.28 M
Total Current Liabilities 9.02 M 10.11 M 9.35 M 6.82 M
Total Liabilities 9.03 M 10.72 M 9.88 M 8.69 M
Shareholder's Equity 63.99 M 107.70 M 103.35 M 83.58 M
Outstanding Stock 27.18 M 24.36 M 18.46 M 14.79 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Total Current Assets 53.94 M 61.60 M 72.81 M 84.98 M
Cash & Cash Equivalents 39.88 M 24.20 M 71.43 M 82.46 M
Total Assets 54.33 M 62.00 M 73.02 M 85.23 M
Total Current Liabilities 6.59 M 6.28 M 9.02 M 10.30 M
Total Liabilities 6.60 M 6.33 M 9.03 M 10.36 M
Shareholder's Equity 47.74 M 55.67 M 63.99 M 74.87 M
Outstanding Stock 28.02 M 27.62 M 27.18 M 27.17 M
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net Cash Flow from Operations -51.92 M -55.26 M -28.20 M -42.99 M
Capital Expenditures 215,000.00 -206,000.00 -408,000.00 -727,000.00
Net Cash Flow from Investing Activities 215,000.00 28.06 M 31.37 M -33.41 M
Net Cash Flow from Financial Activities 10.19 M 59.16 M 50.92 M 83.02 M
Free Cash Flow -51.70 M -55.47 M -28.61 M -43.71 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net Cash Flow from Operations -9.97 M -55.26 M -28.20 M -42.99 M
Capital Expenditures -4,000.00 4,000.00 93,000.00 164,000.00
Net Cash Flow from Investing Activities 23.35 M -35.48 M 93,000.00 164,000.00
Net Cash Flow from Financial Activities 2.31 M 1.61 M 37,000.00 44,000.00
Free Cash Flow -9.98 M -13.35 M -11.38 M -11.63 M
Key Ratios (Market Close Nov 30, 2020)
Valuation Ratios 2020 2019 2018 2017
P/E Ratio -1.61 -1.37 -1.23 -3.64
Price to Sales Ratio 44.91 173.40 111.31 328.98
Price to Book Ratio 1.18 3.82 2.14 4.38
Enterprise Value to EBIT 0.00 -5.00 -5.00 -7.00
Enterprise Value to EBITDA 0.12 -5.33 -5.31 -7.06
Profitability Ratios 2020 2019 2018 2017
Revenue Growth - - - -
Net Income Growth - - - -
ROA - - -64.80% -71.30%
ROE - - -74.20% -78.80%
Liquidity Ratios 2020 2019 2018 2017
Working Capital 63.79 M 106.51 M 101.69 M 56.43 M
Current Ratio 8.07 11.54 11.87 9.28
Efficiency & Capital Structure Ratios 2020 2019 2018 2017
Debt Equity Ratio 0.14 0.10 0.10 0.10
Asset Turnover Ratio - - 0.01 0.01
Scratchpad (max of 30 tickers)
Symbol Last Price Change
Empty Scratchpad
Portfolio (max of 30 tickers)
Login is required to view your portfolio.